𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Intraperitoneal infusion of doxorubicin in the treatment of gynecologic carcinomas

✍ Scribed by Roboz, John ;Jacobs, Allan J. ;Holland, James F. ;Deppe, Gunter ;Cohen, Carmel J.


Publisher
John Wiley and Sons
Year
1981
Tongue
English
Weight
368 KB
Volume
9
Category
Article
ISSN
0098-1532

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Intraperitoneally administered doxorubicin yields high local concentrations that are expected to deliver higher doses to clinically important peritoneal and lymphatic metastatic sites. Two infusions of 20 mg and 30 mg in a patient with residual microscopic intraperitoneal ovarian cancer eradicated her disease. Quantification of serum doxorubicin by HPLC revealed significant levels of the drug and its major metabolite lasting 72 hours. A 50‐mg infusion induced complete remission in endometrial carcinoma; the patient died in 6 months without evidence of abdominal tumor. Complications due to subcutaneous infiltration of doxorubicin and possible systemic effects of sustained high levels of the drug need further investigation to enable the full exploitation of this modality.


πŸ“œ SIMILAR VOLUMES


Intracavitary brachytherapy in the treat
✍ Eifel, Patricia J. πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 137 KB πŸ‘ 2 views

Modern intracavitary brachytherapy carefully combined with megavoltage external beam radiotherapy is responsible for the high cure rates achieved with radiation treatment of invasive cervical cancers. Pelvic disease recurrence is rare after treatment of patients with tumors <5 cm in diameter, and ev

Neodymium:YAG Laser in the Treatment of
✍ Helmut F. Schellhas; Burhkard Weppelmann πŸ“‚ Article πŸ“… 1983 πŸ› John Wiley and Sons 🌐 English βš– 289 KB πŸ‘ 2 views

The Nd:YAG laser has been used for tumor volume reduction of recurrent gynecologic malignant tumors after previous radiation therapy. The localization of the tumor did not allow conventional surgical resection or surgery was contraindicated because of severe medical problems. Hemorrhage caused by re

Mitotane associated with etoposide, doxo
✍ Alfredo Berruti; Massimo Terzolo; Anna Pia; Alberto Angeli; Luigi Dogliotti πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 83 KB πŸ‘ 2 views

BACKGROUND. The use of either mitotane or chemotherapy in the treatment of advanced adrenocortical carcinoma (ACC) has led to scanty and controversial results. The recent finding that mitotane is able to reverse in vitro multidrug resistance has provided a rational basis for combining this agent wit